Better Invesco Healthcare ETF: PJP Targeting Pharmaceuticals vs. RSPH's Broader Sector Lens PJP's one-year return beats RSPH's, but RSPH offers broader diversification across 61 healthcare holdings at a lower expense ratio.
Atour's 2026 Outlook: Asset-Light Expansion Scales Hotel Network to 2,175 Locations This under-the-radar hospitality stock boasts a Superscore of 79 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.
Massive News for Chipotle and Starbucks Investors In case you forgot, the current CEO of Starbucks is the former CEO of Chipotle.
Is Coca Cola an Excellent Dividend Stock to Buy Right Now in October? Coca-Cola has a greater market share in away-from-home channels, such as restaurants.
Got $2,000? 2 Natural Gas Pipeline Stocks to Buy Before Winter. Energy Transfer and The Williams Companies are all solid midstream plays.
How Much Would You Need to Invest in These 5 Pharma Stocks to Earn $1,000 a Month in Dividends? You'll need to generate $12,000 a year in dividends to average $1k per month from Amgen, Pfizer, J&J, AbbVie, and Bristol Myers Squibb.
NICE Stock Analysis: Buy or Sell? A lower price alone is not enough to make a stock a buying opportunity.
Massive Update for AMD Stock Investors The best business in the world could make a poor investment if the price is too high.
I'd Put $500 Into Each of These 5 Dividend Stocks and Throw Away the Statement Because I own stocks like these, I don't worry about my brokerage statements, even though I'm invested in sectors that are currently out of favor.
Consumer Check-In & AI’s Progress Sales are down, guidance has been rough, and with oil and interest rates rising, what is the future for the consumer?
Better Artificial Intelligence Stock: Arm vs. Marvell Technology Arm commands smartphone architecture and is moving into AI CPUs; Marvell dominates data center connectivity with 32.6% net margins.
Can CoreWeave Unseat Amazon Web Services as the Top Cloud Provider? The neocloud company is a rising star, but the hyperscaler has a massive head start.
3 Must-Know COLA Facts Before the Big Announcement Social Security's cost-of-living adjustment (COLA) for 2027 is expected to be announced Oct. 14. What might it mean for you?
Canopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026? Canopy pursues a lean U.S.-focused strategy while Tilray has diversified into beverages, but their diverging paths and financial profiles reveal starkly different risk-reward profiles for 2026.
Firefly Aerospace vs. Rocket Lab: Which Industrials Stock Is a Better Buy in 2026? Firefly's hypergrowth masks massive cash burn, while Rocket Lab trades at a premium despite better financial discipline. One valuation gap may matter more than you think.
